Skip to main content

Table 3 Multivariable-adjusted HR estimates for the 10-mg/dl increase in LDL-C with or without threshold

From: Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events

LDL-C (mg/dl)

Primary composite outcome

Cardiovascular death

Myocardial infarction

Ischemic stroke

Hemorrhagic stroke

HR (95% CI)a

−2 LLb

HR (95% CI)a

−2 LLb

HR (95% CI)a

−2 LLb

HR (95% CI)a

−2 LLb

HR (95% CI)a

−2 LLb

≥0 (no-threshold model)

1.05

(1.00–1.10)

7971.5

1.04

(0.95–1.12)

2535.0

1.08

(0.97–1.20)

1442.7

1.01

(0.92–1.10)

2183.3

0.89

(0.78–1.03)

944.2

≥40

1.05

(1.00–1.10)

7971.7

1.04

(0.95–1.12)

2535.0

1.08

(0.97–1.20)

1442.8

1.00

(0.92–1.10)

2183.3

0.88

(0.76–1.02)

943.9

≥50

1.05

(1.00–1.10)

7971.4

1.04

(0.95–1.13)

2534.9

1.08

(0.97–1.20)

1443.0

1.00

(0.92–1.10)

2183.3

0.87

(0.75–1.02)

943.7

≥60

1.06

(1.01–1.11)

7970.7

1.04

(0.96–1.15)

2534.6

1.09

(0.97–1.22)

1442.7

1.01

(0.92–1.12)

2183.3

0.86

(0.73–1.02)

943.7

≥70

1.07

(1.01–1.13)

7970.1

1.04

(0.97–1.18)

2533.8

1.11

(0.98–1.25)

1442.3

1.01

(0.90–1.13)

2183.3

0.87

(0.72–1.07)

944.8

≥80

1.07

(1.01–1.15)

7971.2

1.04

(0.98–1.23)

2533.5

1.11

(0.96–1.29)

1442.8

1.00

(0.87–1.15)

2183.3

0.92

(0.72–1.16)

946.2

≥90

1.07

(0.99–1.16)

7973.0

1.04

(0.96–1.28)

2533.9

1.10

(0.92–1.33)

1443.7

1.00

(0.84–1.19)

2183.3

0.96

(0.72–1.28)

946.7

≥100

1.06

(0.94–1.19)

7974.7

1.04

(0.92–1.35)

2534.6

1.06

(0.81–1.38)

1444.6

1.01

(0.79–1.28)

2183.3

0.95

(0.63–1.43)

946.7

≥110

1.07

(0.90–1.26)

7975.0

1.04

(0.90–1.50)

2534.6

1.01

(0.66–1.55)

1444.7

0.97

(0.67–1.14)

2183.3

0.88

(0.45–1.17)

946.6

  1. CI confidence interval, HR hazard ratio, LDL-C low-density lipoprotein cholesterol, LL log-likelihood
  2. aPer 10-mg/dl increase in LDL-C, adjusted for gender, age (<65 or 65≤ years), obesity (body mass index <25 or 25≤ kg/m2), diabetes mellitus, hsCRP (<1.0 or 1.0≤ mg/dl), TG (<150 or 150≤ mg/dl), HDL-C (<40 or 40≤ mg/dl), drug use (beta blocker, DAPT, or ACEI/ARB), disease history (MI, unstable angina, PCI, CABG, stroke, AF, malignant tumor, chronic heart failure, hypertension, chronic kidney disease), current smoking, and randomized group (pitavastatin 1 mg/day or 4 mg/day)
  3. bThe smallest value (indicated by bold number) is the best-fitted model